Powerfleet and MiX Telematics Announce Shareholders Meetings to Vote on Proposed Business Combination
Completion of Regulatory Milestones Results in Scheduled Shareholders Meetings WOODCLIFF LAKE, N.J., Jan. 30, 2024 /PRNewswire/ — Powerfleet, Inc. (Nasdaq: PWFL) and MiX Telematics Limited (NYSE: MIXT, JSE: MIX) today announced that their respective shareholders meetings will be held virtuall
Introducing EuroBar, the Bar Station where Functionality meets Design
MINNEAPOLIS, Jan. 30, 2024 /PRNewswire/ — EuroBar proudly introduces a new bar station with a level of sophistication, unmatched functionality, and ergonomic design that is setting a new benchmark in the industry. Inspired by the European bars’ elegance and effectiveness, EuroBar ushe
Indian Lithium Iron Phosphate Batteries Market Report 2023-2024 and 2028
DUBLIN, Jan. 30, 2024 /PRNewswire/ — The “Lithium Iron Phosphate Batteries Market in India, 2024″ report has been added to ResearchAndMarkets.com’s offering. A comprehensive industry analysis signals expansion within India’s Lithium Iron Phosphate (LiFePO4) battery ma
FlexEnable launches flexible active optics evaluation kits for AR and VR
CAMBRIDGE, England, Jan. 30, 2024 /PRNewswire/ — FlexEnable, the leader in the development and production of flexible organic electronics for active optics and displays, today announces the launch of optical evaluation kits for AR and VR devices. The kits include ambient dimming and tunable le
Canon to demonstrate print technology leadership and inspire the Wide Format Graphics Community at FESPA Middle East 2024
DUBAI, UAE, Jan. 30, 2024 /PRNewswire/ — Canon Middle East is participating in FESPA Middle East from January 29 to 31, 2024, at the Dubai Exhibition Centre (Expo City). As the event’s Gold Sponsor, Canon will be showcasing its industry-leading printing solutions, while demonstrating its
FDA Grants Orphan Drug Designation (ODD) Status to NeoImmuneTech’s NT-I7 for Advanced Pancreatic Cancer Treatment
Pancreatic cancer has the highest mortality rate of all major cancers with only a 3% relative-survival-rate at 5-years for the advanced form. [1], [2]Pancreatic tumors are highly resistant to chemotherapy and radiation and there are limited treatment options[2]FDA ODD designation bolsters NeoImmune
FDA Grants Orphan Drug Designation (ODD) Status to NeoImmuneTech’s NT-I7 for Advanced Pancreatic Cancer Treatment
Pancreatic cancer has the highest mortality rate of all major cancers with only a 3% relative-survival-rate at 5-years for the advanced form. [1], [2] Pancreatic tumors are highly resistant to chemotherapy and radiation and there are limited treatment options[2] FDA ODD designation bolsters NeoImmu
Canon to demonstrate print technology leadership and inspire the Wide Format Graphics Community at FESPA Middle East 2024
DUBAI, UAE, Jan. 30, 2024 /PRNewswire/ — Canon Middle East is participating in FESPA Middle East from January 29 to 31, 2024, at the Dubai Exhibition Centre (Expo City). As the event’s Gold Sponsor, Canon will be showcasing its industry-leading printing solutions, while demonstrating its
FlexEnable launches flexible active optics evaluation kits for AR and VR
CAMBRIDGE, England, Jan. 30, 2024 /PRNewswire/ — FlexEnable, the leader in the development and production of flexible organic electronics for active optics and displays, today announces the launch of optical evaluation kits for AR and VR devices. The kits include ambient dimming and tunable le
Indian Lithium Iron Phosphate Batteries Market Report 2023-2024 and 2028
DUBLIN, Jan. 30, 2024 /PRNewswire/ — The “Lithium Iron Phosphate Batteries Market in India, 2024″ report has been added to ResearchAndMarkets.com’s offering. A comprehensive industry analysis signals expansion within India’s Lithium Iron Phosphate (LiFePO4) battery ma
